By Doug Peddicord, PhD, executive director of the Association of Clinical Research Organizations (ACRO)
As the great Yogi Berra once said, “It’s tough to make predictions, especially about the future.” But it is safe to say that after a year of considerable consolidation and change, the CRO industry anticipates continuing and potentially rapid evolution...
Advertising, social media and individualised patient recruitment strategies can improve participation numbers according to clinical site executives, who say they favour a personalised approach.
Only eight of the top 40 CROs are Privacy Shield Framework-certified, says Science Exchange CEO as the company continues to rack up partnerships with pharma companies looking to streamline outsourcing efforts and mitigate risk.
Parexel has launched its first offering as part of its alliance with Microsoft, through which the companies are looking to redefine the life sciences industry, says CRO.
Boehringer Ingelheim is actively collaborating with a variety of partners to help increase patient diversity in clinical trials – and it will continue to identify new partners as it moves forward with its efforts, says SVP.
By Sudip S. Parikh, PhD, senior vice president & managing director, DIA Americas
The healthcare product development ecosystem is undergoing massive changes. Significant transformations are underway in how drugs and medical devices are researched, developed, manufactured, and approved.
Compass Pathways has selected Worldwide Clinical Trials to conduct studies of its investigational psychoactive therapy, designed for patients with treatment-resistant depression.
CTI Clinical Trial and Consulting Services (CTI) and Eurotrials have consolidated to create a full-service contract research organization (CRO) with a global footprint.
Plasticell has teamed with Anthony Nolan to access the latter’s cord-blood bank and boost patient recruitment for its allogeneic haematopoietic stem cell transplantation (HSCT) therapy trials.
Science 37 and Otsuka Pharmaceutical have announced a strategic collaboration through which the global healthcare company aims to explore patient-centric clinical trials – “with fewer physical restrictions and greater efficiencies,” says CEO.
The US Food and Drug Administration (FDA) has released a new draft guidance as part of its stated commitment to assist sponsors and expedite drug development for rare pediatric diseases.
Crucial Data Solutions, Inc. and its strategic partner Zircon Technologies have teamed up to release a “first-of-its-kind” software solution developed to accelerate the clinical trials process.
Blue Oak Pharmaceuticals, Inc. and PGI Drug Discovery LLC (PsychoGenics) have entered into a drug discovery partnership to optimize novel treatments for brain disorders and psychiatric conditions.
ERT’s purchase of iCardiac Technologies follows three months after its purchase Biomedical Systems, the additions of which further increase the company’s portfolio of cardiac safety solutions.
By Dennis Salotti, vice president of operations, The Avoca Group
Making the shift in the pharmaceutical industry from a risk-averse approach to overseeing clinical trials to a risk-based approach is – quite frankly – earthshaking.
Transitioning to a single strategic contract research organization (CRO) reduced Bayer’s administrative burden, but the restructuring was met with some resistance, said the firm.
Clinical research’s sordid past has “left a stain” on the medical community as it tries to gain trust among minority populations and increase clinical trial participation, which remains staggeringly low, says Northwell Health senior VP.
Avista Capital Partners has signed an agreement to acquire United BioSource (UBC), adding another pharmaceutical service provider to the firm’s list of current and historical investments.
Clinerion has expanded its patient recruitment system (PRS) platform to provide its clients, pharma companies, and contract research organizations (CROs) greater access to potential clinical trial participants.
Icon plc has launched a new digital solution aimed at increasing the efficiency and quality of patient eligibility assessments as the industry continues to struggle with clinical trial recruitment.
A Chinese regulatory institute has opened a non-animal testing laboratory – a model for regulatory bodies to show that implementing alternative methods into government laboratories is achievable, says IIVS president.
Quanticate has launched an upgraded statistical monitoring service following the ICH’s good clinical practice (GCP) E6(R2) addendum designed to streamline clinical trials.
The industry is expected to use an increasing amount of real world evidence, including social media data, which will be used to support new drug applications, according to a recent Tufts report.
An increasing number of clinical trials and a decreasing amount of unemployment are creating a significant talent demand as the contract research industry continues to experience employee turnover.
China is determined to become a bigger player in the pharmaceutical market, and with more opportunities for cross-border collaboration, WuXi AppTec aims to be the world’s largest platform for drug research and development.
Peregrine Pharmaceuticals was a biotech company – now, the company is transitioning to a pure-play contract development and manufacturing organization (CDMO) as it sells off its R&D assets.
As the industry continues to externalize components of the supply chain, global regulatory authorities are requiring a “quality-by-design” (QbD) approach to help mitigate risk across the drug development process.
The industry has reached an inflection point with 200 new health-related apps added daily – the use of which could lead to potential annual savings of $46bn, says IQVIA.
QuintilesIMS next week will officially be rebranded as IQVIA – the newest name in the “Mega-CRO” category created by the rapid and ubiquitous consolidation of the industry.
Devana Solutions has released a new platform to help align top performing sites with sponsors and contract research organizations (CROs) as consolidation will make it important to stand out amongst the competition, says CEO.
Marken’s new online tool enables patients to track home deliveries of clinical trial materials, which the company said will improve the direct to patient experience.
Citoxlab Group has acquired Xenometrics, a non-clinical contract research organization (CRO), as client requests continue to increase, says company president.
BioClinica has acquired MDDX Research and Informatics to provide sponsors and CROs access to medical imaging technology, which can determine patient clinical trial eligibility in under an hour, says founder.
ICON and the International Consortium for Health Outcomes Measurement's (ICHOM) pilot patient outcomes platform – known as ‘Globe’ – aims to improve drug development procedures.
Clinical trials conducted outside of India – which test drugs for the Indian market – must include Indian subjects, according to a ruling in India last month.
A proposed regulation in New Jersey demonstrates a lack of understanding regarding the clinical trial process and has clear collateral damage to research conduct in the state, ACRO testifies.
The National Institute of Health (NIH) has awarded Pharmaceutical Product Development, LLC (PPD) a seven-year contract for clinical research support services.
Clinical trial sponsors plan to release more trial results summaries over the next year as part of patient engagement efforts, according to a recent survey.
Kyomed will evaluate the use of a connected bracelet to diagnose sleep apnea through a “holistic approach” the CRO hopes will become a benchmark for the future – and has been nominated for a MedStartup award.
“Bring Your Own Device” (BYOD) in clinical trials will be a “critical component” of future research says Bracket CEO following the company’s acquisition of mProve Health.
